Vision by APOPTOSIS Nutraceuticals — Ingredients, Evidence & Safety

🟢 88/100

This product is generally safe

Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)
Contains proprietary blend — exact ingredient amounts not disclosed
73% of ingredients have research evidence

C Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

2 Capsule(s) Serving Size

30 Servings

Other Combinations Product Type

73% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin A

100 mcg RAE (11% DV)

Vitamin C

200 mg (222% DV)

Vitamin E

20 mg (133% DV)

✅ 1.3× RDA — within safe limits 📚 177 studies (Tier A: 3, B: 90)

RDA 15mg This product: 20mg UL 1000mg

Thiamine

8 mg (667% DV)

📊 6.7× RDA — above typical dose 📚 76 studies (Tier A: 0, B: 33)

RDA 1.2mg This product: 8mg

Riboflavin

8 mg (615% DV)

📊 6.2× RDA — above typical dose 📚 12 studies (Tier A: 0, B: 1)

RDA 1.3mg This product: 8mg

Niacin

40 mg NE (250% DV)

⚠️ Exceeds Tolerable Upper Intake Level by 1.1× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)

RDA 14mg This product: 40mg UL 35mg

Vitamin B12

27 mcg (1125% DV)

📊 11.2× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)

RDA 0.0024mg This product: 0.027mg

Calcium

50 mg (4% DV)

Biotin

800 mcg (2667% DV)

📊 26.7× RDA — above typical dose 📚 26 studies (Tier A: 0, B: 11)

RDA 0.03mg This product: 0.8mg

Magnesium

40 mg (10% DV)

📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)

This product: 40mg

Zinc

32 mg (291% DV)

✅ 2.9× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)

RDA 11mg This product: 32mg UL 40mg

Selenium

8 mcg (15% DV)

✅ Within RDA (0.1× RDA of 0.055 mg) 📚 172 studies (Tier A: 0, B: 67)

RDA 0.055mg This product: 0.008mg UL 0.4mg

Copper

2 mg (222% DV)

✅ 2.2× RDA — within safe limits 📚 36 studies (Tier A: 0, B: 11)

RDA 0.9mg This product: 2mg UL 10mg

Chromium

3.6 mcg (10% DV)

✅ Within RDA (0.1× RDA of 0.035 mg) 📚 197 studies (Tier A: 1, B: 55)

RDA 0.035mg This product: 0.0036mg

Proprietary Blend

481 mg

Other Ingredients

Rice Flour Hypromellose Stearate Silicon Dioxide

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (99% of products) Structure/Function (76% of products) Nutrient (58% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take two (2) veggie capsules once a day. For best results, take 20-30 min before a meal with an 8 fl oz. glass of water or as directed by your healthcare professional. For best results, take capsules consistently for 30 days.

⚠️ Warnings & Precautions

Not for sale or resale in Iran Do not use if safety seal is damaged or missing. Caution: Do not exceed recommended dose.

Keep out of reach of children. Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement. For adult use only

Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

🧪 Formulation Notes

Protect & preserve

Gluten free Dairy free Soy free Nut free Egg free

GMP

Additional Information

Store in a cool, dry place.

APOPTOSIS Nutraceuticals Established 2000

Proudly made in the USA

Product Details

UPC / SKU 8 95979 00049 2

DSLD Entry Date 2025-03-25

Product Type Other Combinations

Form Capsule

Brand APOPTOSIS Nutraceuticals

DSLD ID 323265

Data Updated 2026-04-11

Research Evidence

337 Research Sources

54 Avg Quality Score

161 Meta Analysis

68 Systematic Review

51 Rct

48 Clinical Trial

2 Other

2 Regulatory Source

1 Narrative Review

1 Cochrane Review

1 Guideline

1 Openfda Safety

A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI Cochrane

A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis

Meta Analysis BMJ (Clinical research ed.) 2011

PubMed DOI

A Fortification of staple foods with vitamin A for vitamin A deficiency

Systematic Review The Cochrane database of systematic reviews 2019

PubMed DOI Cochrane

A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age

Narrative Review The Cochrane database of systematic reviews 2016

PubMed DOI Cochrane

A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials

Meta Analysis Journal of sport and health science 2023

PubMed DOI

A Food fortification with multiple micronutrients: impact on health outcomes in general population

Meta Analysis The Cochrane database of systematic reviews 2019

PubMed DOI

A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age

Meta Analysis The Cochrane database of systematic reviews 2024

PubMed DOI

View all evidence for Vitamin A →